Zobrazeno 1 - 10
of 63
pro vyhledávání: '"and Takahiro Sano"'
Autor:
Masahiko Fukatsu, Hiroshi Ohkawara, Hiroshi Takahashi, Hirotaka Mori, Mai Yaginuma, Mamiko Endo, Akiko Shichishima-Nakamura, Takahiro Sano, Kayo Harada-Shirado, Satoshi Kimura, Kazuei Ogawa, Yuko Hashimoto, Takayuki Ikezoe
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1152-1158 (2021)
We here report a 21-year-old male who presented with acute myelomonocytic leukemia (AMML) associated with acquired von Willebrand syndrome (AVWS). To our knowledge, this is the first case of AVWS caused by AMML. In our case, following remission-induc
Externí odkaz:
https://doaj.org/article/3c97175e36194befaab10eef18a0307f
Autor:
Yasuhiro Uchida, Daisuke Koyama, Kazuya Manabe, Kengo Suzuki, Naomi Asano, Mamiko Endo, Masahiko Fukatsu, Takahiro Sano, Kiyohito Hayashi, Motoki Takano, Hiroshi Takahashi, Satoshi Kimura, Takayuki Ikezoe
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 5, p717-720, 4p
Autor:
Koki Ueda, Kazuhiko Ikeda, Takayuki Ikezoe, Kayo Harada-Shirado, Kazuei Ogawa, Yuko Hashimoto, Takahiro Sano, Hiroshi Ohkawara, Satoshi Kimura, Akiko Shichishima-Nakamura, Yuichi Nakamura, Yayoi Shikama, Tsutomu Mori, Philip J. Mason, Monica Bessler, Soji Morishita, Norio Komatsu, Kotaro Shide, Kazuya Shimoda, Shuhei Koide, Kazumasa Aoyama, Motohiko Oshima, Atsushi Iwama, Yasuchika Takeishi
Publikováno v:
Blood Advances, Vol 1, Iss 15, Pp 1001-1015 (2017)
Abstract: High-mobility group AT-hook 2 (HMGA2) is crucial for the self-renewal of fetal hematopoietic stem cells (HSCs) but is downregulated in adult HSCs via repression by MIRlet-7 and the polycomb-recessive complex 2 (PRC2) including EZH2. The HMG
Externí odkaz:
https://doaj.org/article/7d35bd81e24048ababdc3f54d31b7553
Autor:
Hiroshi Takahashi, Hirotaka Mori, Masahiko Fukatsu, Takahiro Sano, Kayo Harada, Masayoshi Oikawa, Yasuchika Takeishi, Satoshi Kimura, Hiroshi Ohkawara, Tsutomu Shichishima, Takayuki Ikezoe
Publikováno v:
Fukushima journal of medical science. 68(3)
Ravulizumab is an anti-C5 antibody approved for treating paroxysmal nocturnal hemoglobinuria (PNH). In August 2019, a 77-year-old Japanese man with PNH, who had been on ravulizumab treatment for 2 years, was hospitalized for chest discomfort and mala
Autor:
Yuko Hashimoto, Takahiro Sano, Kazuei Ogawa, Takayuki Ikezoe, Satoshi Kimura, Hiroshi Ohkawara, Masahiko Fukatsu, Kayo Harada-Shirado, Hirotaka Mori, Hiroshi Takahashi, Akiko Shichishima-Nakamura, Mamiko Endo, Mai Yaginuma
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1152-1158 (2021)
Case Reports in Oncology
Case Reports in Oncology
We here report a 21-year-old male who presented with acute myelomonocytic leukemia (AMML) associated with acquired von Willebrand syndrome (AVWS). To our knowledge, this is the first case of AVWS caused by AMML. In our case, following remission-induc
Autor:
Masahiko Fukatsu, Hiroshi Ohkawara, Xintao Wang, Lobna Alkebsi, Miki Furukawa, Hirotaka Mori, Miwa Fukami, Shin-ichi Fukami, Takahiro Sano, Hiroshi Takahashi, Kayo Harada-Shirado, Satoshi Kimura, Koichi Sugimoto, Kazuei Ogawa, Takayuki Ikezoe
Publikováno v:
Science signaling. 15(724)
The pathogenesis of sepsis-induced acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) has not yet been fully elucidated. Growth arrest–specific 6 (Gas6) has marked effects on hemostasis and reduces inflammation through its interacti
Autor:
Masatsugu Ohta, Masumi Sukegawa, Hirotaka Mori, Satoshi Kimura, Takahiro Sano, Masayuki Mita, Tomiyoshi Saito, Ken-ichi Nakamura, Takayuki Ikezoe, Kayo Harada, Masahiko Fukatsu, Hiroshi Ohkawara, Yoichi Hamazaki, Hiroshi Takahashi
Publikováno v:
Annals of Hematology. 99:359-361
Publikováno v:
IEEJ Transactions on Power and Energy. 139:598-601
Autor:
Yuichi Nakamura, Koki Ueda, Kazumasa Aoyama, Yuko Hashimoto, Atsushi Iwama, Kazuhiko Ikeda, Kotaro Shide, Takahiro Sano, Takayuki Ikezoe, Hiroshi Ohkawara, Monica Bessler, Tsutomu Mori, Satoshi Kimura, Yayoi Shikama, Philip J. Mason, Shuhei Koide, Motohiko Oshima, Kazuei Ogawa, Yasuchika Takeishi, Norio Komatsu, Soji Morishita, Kayo Harada-Shirado, Kazuya Shimoda, Akiko Shichishima-Nakamura
Publikováno v:
Blood Advances. 1:1001-1015
High-mobility group AT-hook 2 (HMGA2) is crucial for the self-renewal of fetal hematopoietic stem cells (HSCs) but is downregulated in adult HSCs via repression by MIRlet-7 and the polycomb-recessive complex 2 (PRC2) including EZH2. The HMGA2 messeng
Autor:
Yuko Hashimoto, Norio Komatsu, Yasuchika Takeishi, Soji Morishita, Takahiro Sano, Kazuei Ogawa, Kazuhiko Ikeda, Takayuki Ikezoe, Hitoshi Ohto, Koki Ueda
Publikováno v:
Internal Medicine
Less than 5% of patients with polycythemia vera (PV) show JAK2 exon 12 mutations. Although PV patients with JAK2 exon 12 mutations are known to develop post-PV myelofibrosis (MF) as well as PV with JAK2V617F, the role of JAK inhibitors in post-PV MF